お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:臨床試験の市場予測・競合動向・成長機会 (~2026年):タイプ・フェーズ・研究設計・適応症・エンドユーザー・企業・地域別
市場調査レポート
商品コード
1002692

臨床試験の市場予測・競合動向・成長機会 (~2026年):タイプ・フェーズ・研究設計・適応症・エンドユーザー・企業・地域別

Global Clinical Trials Market, By Type, By Phase, By Study Design, By Indication, By End User, By Company, By Region, Forecast & Opportunities, 2026

出版日: | 発行: TechSci Research | ページ情報: 英文 113 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

臨床試験の市場予測・競合動向・成長機会 (~2026年):タイプ・フェーズ・研究設計・適応症・エンドユーザー・企業・地域別
出版日: 2021年04月28日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床試験の市場は予測期間中7.10%のCAGRで推移し、2020年の512億5000万米ドルから、2026年には772億米ドルの規模に成長すると予測されています。

新型コロナウイルス感染症 (COVID-19) の発生などから、適切な治療法やワクチンを見つけるための大規模な臨床試験が世界的に行われており、市場成長を推進しています。また、ラボや病院に出向くことなく、被験者から効率的かつ安全にデータを収集できる仮想臨床試験の導入が進んでいることも同市場の大きな成長要因となっています。さらに、パーキンソン病、アルツハイマー病、うつ病などの神経系疾患の増加や、高齢者人口の増加、臨床試験のデジタル化などの要因も今後数年の市場成長を促進すると予測されています。

当レポートでは、世界の臨床試験の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、タイプ・フェーズ・研究設計・適応症・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 製品の概要

第2章 調査手法

第3章 COVID-19の影響

第4章 顧客の声

第5章 エグゼクティブサマリー

第6章 世界市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
  • タイプ別
    • 医薬品
    • 医療機器
  • フェーズ別
    • フェーズI
    • フェーズII
    • フェーズIII
    • フェーズIV
  • 研究設計別
    • 介入的
    • 観察的
    • 拡張アクセス
  • 適応症
    • 自己免疫/炎症
    • 腫瘍
    • CNS
    • 糖尿病
    • 心血管
    • その他
  • エンドユーザー別
    • 臨床研究機関
    • 製薬・バイオテクノロジー企業
    • 臨床試験ラボ
    • その他
  • 企業別
  • 地域別
  • マーケットマップ

第7章 北米市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • フェーズ別
    • 研究設計別
    • 適応症別
    • エンドユーザー別
    • 国別

第8章 欧州市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • フェーズ別
    • 研究設計別
    • 適応症別
    • エンドユーザー別
    • 国別

第9章 アジア太平洋市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • フェーズ別
    • 研究設計別
    • 適応症別
    • エンドユーザー別
    • 国別

第10章 南米市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • フェーズ別
    • 研究設計別
    • 適応症別
    • エンドユーザー別
    • 国別

第11章 中東・アフリカ市場の分析・予測

  • 市場規模・予測
  • 市場シェア・予測
    • タイプ別
    • フェーズ別
    • 研究設計別
    • 適応症別
    • エンドユーザー別
    • 国別

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向

第14章 競合情勢

  • 競合の見通し
  • 企業プロファイル
    • Eli Lilly and Company
    • Sun Pharmaceutical Industries Ltd.
    • Novo Nordisk A/S
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • ICON plc
    • Pharmaceutical Product Development Inc.
    • F. Hoffmann-La Roche AG
    • IQVIA Holdings Inc.
    • Covance Inc.
    • Syneos Health Inc.
    • PRA Health Sciences Inc.
    • Medpace Holdings, Inc.
    • WuXi Apptec Company Ltd.
    • Thermo Fisher Scientific Inc.

第15章 戦略的提言

第16章 当社について・免責事項

図表

List of Figures

  • Figure 1: Global Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 2: Global Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 3: Global Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 4: Global Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 5: Global Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 6: Global Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 7: Global Clinical Trials Market Share, By Company, 2020
  • Figure 8: Global Clinical Trials Market Share, By Region, By Value, 2016-2026F
  • Figure 9: Global Clinical Trials Product Market Map, By Region, By Value, 2016-2026F
  • Figure 10: North America Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 11: North America Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 12: North America Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 13: North America Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 14: North America Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 15: North America Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 16: North America Clinical Trials Market Share, By Country, By Value, 2016-2026F
  • Figure 17: United States Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 18: United States Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 19: United States Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 20: United States Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 21: United States Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 22: United States Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 23: Canada Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 24: Canada Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 25: Canada Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 26: Canada Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 27: Canada Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 28: Canada Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 29: Mexico Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 30: Mexico Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 31: Mexico Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 32: Mexico Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 33: Mexico Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 34: Mexico Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 35: Europe Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 36: Europe Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 37: Europe Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 38: Europe Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 39: Europe Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 40: Europe Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 41: Europe Clinical Trials Market Share, By Country, By Value, 2016-2026F
  • Figure 42: Germany Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 43: Germany Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 44: Germany Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 45: Germany Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 46: Germany Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 47: Germany Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 48: United Kingdom Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 49: United Kingdom Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 50: United Kingdom Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 51: United Kingdom Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 52: United Kingdom Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 53: United Kingdom Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 54: France Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 55: France Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 56: France Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 57: France Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 58: France Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 59: France Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 60: Italy Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 61: Italy Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 62: Italy Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 63: Italy Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 64: Italy Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 65: Italy Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 66: Spain Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 67: Spain Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 68: Spain Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 69: Spain Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 70: Spain Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 71: Spain Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 72: Asia Pacific Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 73: Asia Pacific Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 74: Asia Pacific Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 75: Asia Pacific Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 76: Asia Pacific Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 77: Asia Pacific Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 78: Asia Pacific Clinical Trials Market Share, By Country, By Value, 2016-2026F
  • Figure 79: Japan Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 80: Japan Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 81: Japan Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 82: Japan Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 83: Japan Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 84: Japan Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 85: China Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 86: China Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 87: China Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 88: China Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 89: China Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 90: China Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 91: India Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 92: India Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 93: India Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 94: India Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 95: India Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 96: India Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 97: South Korea Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 98: South Korea Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 99: South Korea Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 100: South Korea Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 101: South Korea Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 102: South Korea Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 103: Australia Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 104: Australia Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 105: Australia Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 106: Australia Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 107: Australia Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 108: Australia Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 109: South America Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 110: South America Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 101: South America Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 102: South America Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 103: South America Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 104: South America Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 105: South America Clinical Trials Market Share, By Country, By Value, 2016-2026F
  • Figure 106: Brazil Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 107: Brazil Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 108: Brazil Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 109: Brazil Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 110: Brazil Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 111: Brazil Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 112: Argentina Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 113: Argentina Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 114: Argentina Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 115: Argentina Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 116: Argentina Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 117: Argentina Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 118: Colombia Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 119: Colombia Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 120: Colombia Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 121: Colombia Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 122: Colombia Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 123: Colombia Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 124: Middle East & Africa Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 125: Middle East & Africa Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 126: Middle East & Africa Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 127: Middle East & Africa Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 128: Middle East & Africa Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 129: Middle East & Africa Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 130: Middle East & Africa Clinical Trials Market Share, By Country, By Value, 2016-2026F
  • Figure 131: South Africa Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 132: South Africa Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 133: South Africa Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 134: South Africa Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 135: South Africa Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 136: South Africa Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 137: Saudi Arabia Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 138: Saudi Arabia Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 139: Saudi Arabia Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 140: Saudi Arabia Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 141: Saudi Arabia Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 142: Saudi Arabia Clinical Trials Market Share, By End User, By Value, 2016-2026F
  • Figure 143: UAE Clinical Trials Market Size, By Value (USD Billion), 2016-2026F
  • Figure 144: UAE Clinical Trials Market Share, By Type, By Value, 2016-2026F
  • Figure 145: UAE Clinical Trials Market Share, By Phase, By Value, 2016-2026F
  • Figure 146: UAE Clinical Trials Market Share, By Study Design, By Value, 2016-2026F
  • Figure 147: UAE Clinical Trials Market Share, By Indication, By Value, 2016-2026F
  • Figure 148: UAE Clinical Trials Market Share, By End User, By Value, 2016-2026F
目次
Product Code: 5082

Title:
Global Clinical Trials Market, By Type (Pharmaceutical Trials Vs Medical Device Trials), By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others), By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing Laboratories, Others), By Company, By Region, Forecast & Opportunities, 2026.

Global clinical trials market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026, registering a CAGR of 7.10% in the next five years. The market is driven by the outbreak of tropical and infectious diseases such as COVID-19, which has led to extensive clinical trials around the world in order to find the suitable treatment and vaccine. The growing adoption of virtual clinical trials that allow to collect data efficiently and safely from participants without the requirement of traveling to the lab or hospital is also acting as a major growth driver for the global clinical trials market. Moreover, the growing prevalence of neurological diseases such as Parkinson's, Alzheimer's and depression, coupled with growing geriatric population are some other key factors creating the need for clinical trials. Also, the digitization of clinical trials is anticipated to propel the growth of this market in the coming years.

Additionally, the increasing prevalence of chronic diseases and growing need for personalized drugs are some other key factors propelling the growth of the global clinical trials market. Governments in various economies are also providing favorable support for clinical trials in order to find the cure for deadly diseases like coronavirus. The increasing expenditure on R&D activities and rise in biotechnology firms is also anticipated to drive the market growth through 2026.

Global clinical trials market can be segmented based on type, phase, study design, indication, end user and region. Based on indication, the market can be segmented into autoimmune/inflammation, oncology, CNS, diabetes, cardiovascular and others. Among these, the oncology segment dominated the market until 2020 and is expected to maintain its dominance during the forecast period as well owing to increasing expenditure by the medical industry towards preclinical and clinical development of oncology drugs.

Regionally, Asia Pacific is anticipated to witness the fastest CAGR through 2026 owing to a large patient pool suffering from coronavirus and increasing number of biotechnology firms undergoing COVID-19 trials. The favorable support by governments in countries such as India and South Korea is also leading to extensive clinical trials in the two countries.

Major companies operating in the global clinical trials market include: Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Novo Nordisk A/S, Pfizer Inc., GlaxoSmithKline plc, ICON plc, Pharmaceutical Product Development Inc., F. Hoffmann-La Roche AG, IQVIA Holdings Inc., Covance Inc., Syneos Health Inc., PRA Health Sciences Inc., Medpace Holdings, Inc., WuXi Apptec Company Ltd., Thermo Fisher Scientific Inc., among others. The market players are undertaking growth strategies such as mergers and acquisitions along with new product launches to increase their share in the global clinical trials market.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze the historical growth in the market size of the global clinical trials market from 2016 to 2020.
  • To estimate and forecast the global clinical trials market from 2021 to 2026 and growth rate until 2026.
  • To forecast the global clinical trials market based on type, phase, study design, indication, end user, company and regional distribution.
  • To identify drivers and challenges for the global clinical trials market.
  • To examine competitive developments such as expansions, new product launches, mergers and acquisitions, etc. in the global clinical trials market.
  • To identify and analyze the profile of leading players operating in the global clinical trials market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of CROs across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global clinical trials market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Clinical trial research organisations, companies/partners and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to clinical trials
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as clinical trials service provider companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, the global clinical trials market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Global Clinical Trials Market, By Type:

Pharmaceutical Trials

Medical Device Trials

  • Global Clinical Trials Market, By Phase:

Phase I

Phase II

Phase III

Phase IV

  • Global Clinical Trials Market, By Study Design:

Interventional

Observational

Expanded Access

  • Global Clinical Trials Market, By Indication:

Autoimmune

Oncology

CNS

Diabetes

Cardiovascular

Others

  • Global Clinical Trials Market, By End User:

Clinical Research Organizations

Pharmaceutical and Biotechnological Companies

Clinical Testing Laboratories

Others

  • Global Clinical Trials Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain

Asia-Pacific

  • Japan
  • China
  • India
  • South Korea
  • Australia

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in the global clinical trials market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information:

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis:

  • Profit margin analysis in case of direct and indirect sales channel.

Table of Contents

1. Global Clinical Trials Market Overview

2. Research Methodology

3. Impact of COVID-19 on Global Clinical Trials Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness in Terms of Experimental Drugs
  • 5.2. Labeling Characterization of the Drugs
  • 5.3. Patient Satisfaction Level

6. Global Clinical Trials Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Pharmaceutical Trials Vs Medical Device Trials)
    • 6.2.2. By Phase (Phase I, Phase II, Phase III, Phase IV)
    • 6.2.3. By Study Design (Interventional, Observational, Expanded Access)
    • 6.2.4. By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others)
    • 6.2.5. By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing Laboratories, Others)
    • 6.2.6. By Company (2020)
    • 6.2.7. By Region
  • 6.3. Market Map

7. North America Clinical Trials Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Phase
    • 7.2.3. By Study Design
    • 7.2.4. By Indication
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Clinical Trials Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Phase
        • 7.3.1.2.3. By Study Design
        • 7.3.1.2.4. By Indication
        • 7.3.1.2.5. By End User
    • 7.3.2. Canada Clinical Trials Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Phase
        • 7.3.2.2.3. By Study Design
        • 7.3.2.2.4. By Indication
        • 7.3.2.2.5. By End User
    • 7.3.3. Mexico Clinical Trials Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Phase
        • 7.3.3.2.3. By Study Design
        • 7.3.3.2.4. By Indication
        • 7.3.3.2.5. By End User

8. Europe Clinical Trials Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Phase
    • 8.2.3. By Study Design
    • 8.2.4. By Indication
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Clinical Trials Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Phase
        • 8.3.1.2.3. By Study Design
        • 8.3.1.2.4. By Indication
        • 8.3.1.2.5. By End User
    • 8.3.2. United Kingdom Clinical Trials Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Phase
        • 8.3.2.2.3. By Study Design
        • 8.3.2.2.4. By Indication
        • 8.3.2.2.5. By End User
    • 8.3.3. France Clinical Trials Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Phase
        • 8.3.3.2.3. By Study Design
        • 8.3.3.2.4. By Indication
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Clinical Trials Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Phase
        • 8.3.4.2.3. By Study Design
        • 8.3.4.2.4. By Indication
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Clinical Trials Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Phase
        • 8.3.5.2.3. By Study Design
        • 8.3.5.2.4. By Indication
        • 8.3.5.2.5. By End User

9. Asia-Pacific Clinical Trials Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Phase
    • 9.2.3. By Study Design
    • 9.2.4. By Indication
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. Japan Clinical Trials Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Phase
        • 9.3.1.2.3. By Study Design
        • 9.3.1.2.4. By Indication
        • 9.3.1.2.5. By End User
    • 9.3.2. China Clinical Trials Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Phase
        • 9.3.2.2.3. By Study Design
        • 9.3.2.2.4. By Indication
        • 9.3.2.2.5. By End User
    • 9.3.3. India Clinical Trials Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Phase
        • 9.3.3.2.3. By Study Design
        • 9.3.3.2.4. By Indication
        • 9.3.3.2.5. By End User
    • 9.3.4. South Korea Clinical Trials Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Phase
        • 9.3.4.2.3. By Study Design
        • 9.3.4.2.4. By Indication
        • 9.3.4.2.5. By End User
    • 9.3.5. Australia Clinical Trials Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Phase
        • 9.3.5.2.3. By Study Design
        • 9.3.5.2.4. By Indication
        • 9.3.5.2.5. By End User

10. South America Clinical Trials Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Phase
    • 10.2.3. By Study Design
    • 10.2.4. By Indication
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Trials Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Phase
        • 10.3.1.2.3. By Study Design
        • 10.3.1.2.4. By Indication
        • 10.3.1.2.5. By End User
    • 10.3.2. Argentina Clinical Trials Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Phase
        • 10.3.2.2.3. By Study Design
        • 10.3.2.2.4. By Indication
        • 10.3.2.2.5. By End User
    • 10.3.3. Colombia Clinical Trials Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Phase
        • 10.3.3.2.3. By Study Design
        • 10.3.3.2.4. By Indication
        • 10.3.3.2.5. By End User

11. Middle East and Africa Clinical Trials Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Phase
    • 11.2.3. By Study Design
    • 11.2.4. By Indication
    • 11.2.5. By End User
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Clinical Trials Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Phase
        • 11.3.1.2.3. By Study Design
        • 11.3.1.2.4. By Indication
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Clinical Trials Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Phase
        • 11.3.2.2.3. By Study Design
        • 11.3.2.2.4. By Indication
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Clinical Trials Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Phase
        • 11.3.3.2.3. By Study Design
        • 11.3.3.2.4. By Indication
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Eli Lilly and Company
    • 14.2.2. Sun Pharmaceutical Industries Ltd.
    • 14.2.3. Novo Nordisk A/S
    • 14.2.4. Pfizer Inc.
    • 14.2.5. GlaxoSmithKline plc
    • 14.2.6. ICON plc
    • 14.2.7. Pharmaceutical Product Development Inc.
    • 14.2.8. F. Hoffmann-La Roche AG
    • 14.2.9. IQVIA Holdings Inc.
    • 14.2.10. Covance Inc.
    • 14.2.11. Syneos Health Inc.
    • 14.2.12. PRA Health Sciences Inc.
    • 14.2.13. Medpace Holdings, Inc.
    • 14.2.14. WuXi Apptec Company Ltd.
    • 14.2.15. Thermo Fisher Scientific Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.